Marzia Palma

Marzia Palma

UNVERIFIED PROFILE

Are you Marzia Palma?   Register this Author

Register author
Marzia Palma

Marzia Palma

Publications by authors named "Marzia Palma"

Are you Marzia Palma?   Register this Author

21Publications

304Reads

50Profile Views

Targeting the Immune Microenvironment in Lymphomas of B-Cell Origin: From Biology to Clinical Application.

Cancers (Basel) 2019 Jun 29;11(7). Epub 2019 Jun 29.

Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3390/cancers11070915DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6678966PMC
June 2019

T cells in chronic lymphocytic leukemia display dysregulated expression of immune checkpoints and activation markers.

Haematologica 2017 03 7;102(3):562-572. Epub 2016 Dec 7.

Immune and Gene Therapy Laboratory, Department of Oncology & Pathology, Cancer Centre Karolinska, Karolinska Institutet, Stockholm, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3324/haematol.2016.151100DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5394965PMC
March 2017

Dendritic cell regulation of NK-cell responses involves lymphotoxin-α, IL-12, and TGF-β.

Eur J Immunol 2015 Jun 17;45(6):1783-93. Epub 2015 Apr 17.

Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/eji.201444885
Publisher Site
http://dx.doi.org/10.1002/eji.201444885DOI Listing
June 2015

The tyrosine kinase receptor ROR1 is constitutively phosphorylated in chronic lymphocytic leukemia (CLL) cells.

PLoS One 2013 24;8(10):e78339. Epub 2013 Oct 24.

Department of Oncology-Pathology, Immune and Gene therapy Lab, Cancer Center Karolinska (CCK), Karolinska University Hospital Solna and Karolinska Institute, Stockholm, Sweden.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0078339PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3813472PMC
February 2015

Telomere length and expression of human telomerase reverse transcriptase splice variants in chronic lymphocytic leukemia.

Exp Hematol 2013 Jul 30;41(7):615-26. Epub 2013 Mar 30.

Immune and Gene Therapy Laboratory, Department of Oncology and Pathology, Cancer Centre Karolinska, Karolinska Institutet, Stockholm, Sweden.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S0301472X130012
Publisher Site
http://dx.doi.org/10.1016/j.exphem.2013.03.008DOI Listing
July 2013

T cells from indolent CLL patients prevent apoptosis of leukemic B cells in vitro and have altered gene expression profile.

Cancer Immunol Immunother 2013 Jan 27;62(1):51-63. Epub 2012 Jun 27.

Institute of Cancer, Barts and The London School of Medicine and Dentistry, Charterhouse Square, London, EC1M 6BQ, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00262-012-1300-yDOI Listing
January 2013

The future of cancer vaccines for non-small-cell lung cancer: ongoing trials.

Clin Lung Cancer 2008 Feb;9 Suppl 1:S37-44

Karolinska Institutet, Department of Oncology-Pathology, Cancer Centrum Karolinska, Stockholm, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3816/clc.2008.s.006DOI Listing
February 2008

Telomerase (hTERT 611-626) serves as a tumor antigen in B-cell chronic lymphocytic leukemia and generates spontaneously antileukemic, cytotoxic T cells.

Exp Hematol 2007 Feb;35(2):297-304

Immune and Gene Therapy Lab, Cancer Centre Karolinska, Department of Oncology-Pathology, Karolinska Institute, Stockholm, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.exphem.2006.10.006DOI Listing
February 2007

Clinical results of vaccine therapy for cancer: learning from history for improving the future.

Adv Cancer Res 2006 ;95:147-202

Department of Oncology, Cancer Centre Karolinska, Karolinska University, Hospital Solna, SE-171 76 Stockholm, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S0065-230X(06)95005-2DOI Listing
September 2006

BRCA1 and BRCA2: the genetic testing and the current management options for mutation carriers.

Crit Rev Oncol Hematol 2006 Jan 6;57(1):1-23. Epub 2005 Dec 6.

Department of Experimental Medicine and Pathology, University La Sapienza, Policlinico Umberto I, Viale Regina Elena 324, 00161 Rome, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.critrevonc.2005.05.003DOI Listing
January 2006

Specific role for p300/CREB-binding protein-associated factor activity in E2F1 stabilization in response to DNA damage.

J Biol Chem 2004 Jul 3;279(29):30830-5. Epub 2004 May 3.

Department of Experimental Medicine and Pathology, University of Rome La Sapienza, 00161 Rome, Italy.

View Article

Download full-text PDF

Source
http://www.jbc.org/lookup/doi/10.1074/jbc.M402403200
Publisher Site
http://dx.doi.org/10.1074/jbc.M402403200DOI Listing
July 2004

Hepatic arterial continuous infusion (HACI) of oxaliplatin in patients with unresectable liver metastases from colorectal cancer.

Anticancer Res 2003 Mar-Apr;23(2C):1917-22

Department of Experimental Medicine and Pathology, University of Rome La Sapienza, Rome, Italy.

View Article

Download full-text PDF

Source
July 2003

Atrial fibrillation during adjuvant chemotherapy with docetaxel: a case report.

Tumori 2002 Nov-Dec;88(6):527-9

Medical Oncology, Department of Experimental Medicine and Pathology, University of Rome La Sapienza, Rome, Italy.

View Article

Download full-text PDF

Source
March 2003